Mary Slatter Selected Research

Type 1 Hyper-IgM Immunodeficiency Syndrome

4/2017

Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary Slatter Research Topics

Disease

9	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2023 - 02/2014
9	Infections 02/2023 - 03/2011
8	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2022 - 03/2011
3	Bronchiolitis Obliterans Syndrome 12/2023 - 01/2019
3	Primary Immunodeficiency Diseases 12/2021 - 01/2018
2	COVID-19 02/2023 - 01/2021
2	Immune System Diseases (Immune Disorders) 01/2022 - 03/2009
2	Lymphopenia (Lymphocytopenia) 01/2021 - 01/2017
2	Cytopenia 01/2020 - 01/2018
2	Viremia 01/2018 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2017
2	Chronic Granulomatous Disease 01/2016 - 02/2014
2	Severe combined immunodeficiency due to adenosine deaminase deficiency 06/2014 - 10/2012
1	Poliomyelitis (Polio) 01/2023
1	Fever (Fevers) 01/2022
1	Activated PI3K-delta Syndrome 01/2022
1	Hemorrhage 12/2021
1	Leukocyte adhesion deficiency type 1 12/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Schimke immunoosseous dysplasia 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Thrombotic Microangiopathies 01/2020
1	Pathologic Complete Response 01/2020
1	Tetanus 01/2020
1	Liver Diseases (Liver Disease) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 04/2017
1	Immune Reconstitution Inflammatory Syndrome 01/2017
1	Reticular dysgenesis 01/2017
1	Diarrhea 01/2017
1	Colic (Abdominal Cramps) 01/2017
1	Warts (Wart) 11/2016
1	Agammaglobulinemia (Hypogammaglobulinemia) 11/2016
1	Primary Myelofibrosis (Myelosclerosis) 11/2016
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Lymphoma (Lymphomas) 01/2016
1	Leukemia 01/2016
1	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 01/2015
1	Hypothyroidism 08/2013
1	Graves Disease (Basedow Disease) 08/2013
1	Wiskott-Aldrich Syndrome 08/2011
1	Failure to Thrive 05/2011
1	Sepsis (Septicemia) 05/2011

Drug/Important Bio-Agent (IBA)

2	Alemtuzumab (Campath)FDA Link 12/2023 - 01/2020
2	VaccinesIBA 01/2023 - 01/2020
2	Adenosine DeaminaseIBA 01/2022 - 10/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2011
2	SteroidsIBA 01/2020 - 01/2016
2	Sirolimus (Rapamycin)FDA Link 01/2020 - 01/2018
2	treosulfanIBA 01/2016 - 01/2016
1	LactamsIBA 01/2022
1	Immunoglobulin A (IgA)IBA 11/2021
1	blinatumomabIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	STAT1 Transcription FactorIBA 01/2018
1	brincidofovirIBA 01/2017
1	Cidofovir (Vistide)FDA Link 01/2017
1	Busulfan (Busulfex)FDA Link 01/2016
1	Indicators and Reagents (Reagents)IBA 06/2014
1	Janus Kinase 3IBA 06/2014
1	Long-Acting Thyroid Stimulator (LATS)IBA 08/2013
1	Thyroid HormonesIBA 08/2013
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2013
1	Thyroxine (Levothyroxine)FDA LinkGeneric 08/2013
1	purineIBA 10/2012
1	EnzymesIBA 10/2012
1	IntegrinsIBA 03/2009

Therapy/Procedure

14	Hematopoietic Stem Cell Transplantation 12/2023 - 03/2011
11	Cell Transplantation 01/2022 - 08/2011
9	Transplantation 01/2019 - 03/2011
6	Stem Cell Transplantation 12/2023 - 02/2014
1	Artificial Respiration (Mechanical Ventilation) 02/2023
1	Enzyme Replacement Therapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Therapeutics 01/2018